These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38257138)

  • 41. Higher versus lower protein intake in formula-fed low birth weight infants.
    Fenton TR; Al-Wassia H; Premji SS; Sauve RS
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD003959. PubMed ID: 32573771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI).
    von Berg A; Filipiak-Pittroff B; Krämer U; Link E; Bollrath C; Brockow I; Koletzko S; Grübl A; Heinrich J; Wichmann HE; Bauer CP; Reinhardt D; Berdel D;
    J Allergy Clin Immunol; 2008 Jun; 121(6):1442-7. PubMed ID: 18539195
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial.
    Kouwenhoven SMP; Antl N; Finken MJJ; Twisk JWR; van der Beek EM; Abrahamse-Berkeveld M; van de Heijning BJM; Schierbeek H; Holdt LM; van Goudoever JB; Koletzko BV
    Am J Clin Nutr; 2020 May; 111(5):962-974. PubMed ID: 31868201
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Z-score of weight for age of infants with atopic dermatitis and cow's milk allergy fed with a rice-hydrolysate formula during the first two years of life.
    Savino F; Castagno E; Monti G; Serraino P; Peltran A; Oggero R; Fanaro S; Vigi V; Silvestro L
    Acta Paediatr Suppl; 2005 Oct; 94(449):115-9. PubMed ID: 16214777
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of a Novel Infant Formula on Weight Gain, Body Composition, Safety and Tolerability to Infants: The INNOVA 2020 Study.
    Plaza-Diaz J; Ruiz-Ojeda FJ; Morales J; de la Torre AIC; García-García A; de Prado CN; Coronel-Rodríguez C; Crespo C; Ortega E; Martín-Pérez E; Ferreira F; García-Ron G; Galicia I; Santos-García-Cuéllar MT; Maroto M; Ruiz P; Martín-Molina R; Viver-Gómez S; Gil A
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Growth of healthy term infants fed partially hydrolyzed whey-based infant formula: a randomized, blinded, controlled trial.
    Borschel MW; Choe YS; Kajzer JA
    Clin Pediatr (Phila); 2014 Dec; 53(14):1375-82. PubMed ID: 25009115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Growth and Tolerance of Preterm Infants Fed a New Extensively Hydrolyzed Liquid Human Milk Fortifier.
    Kim JH; Chan G; Schanler R; Groh-Wargo S; Bloom B; Dimmit R; Williams L; Baggs G; Barrett-Reis B
    J Pediatr Gastroenterol Nutr; 2015 Dec; 61(6):665-71. PubMed ID: 26488118
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nutritional safety and suitability of a specific protein hydrolysate derived from whey protein concentrate and used in an infant and follow-on formula manufactured from hydrolysed protein by Danone Trading ELN B.V.
    ; Castenmiller J; de Henauw S; Hirsch-Ernst KI; Kearney J; Knutsen HK; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Bresson JL; Castle L; Fewtrell M; Przyrembel H; Dumas C; Titz A; Turck D
    EFSA J; 2020 Nov; 18(11):e06304. PubMed ID: 33312234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypoallergenicity assessment of an extensively hydrolyzed whey-protein formula in cow's milk allergic infants.
    Dahdah L; Roelofs M; Knipping K; de Vries E; Rijnierse A; Garssen J; Brand PLP; Fiocchi A
    Pediatr Allergy Immunol; 2022 Jun; 33(6):e13814. PubMed ID: 35754130
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nutritional safety and suitability of a specific protein hydrolysate derived from whey protein concentrate and used in an infant and follow-on formula manufactured from hydrolysed protein by HIPP-Werk Georg Hipp OHG (dossier submitted by meyer.science GmbH).
    ; Bohn T; Castenmiller J; de Henauw S; Hirsch-Ernst KI; Katrine Knutsen H; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Bresson JL; Castle L; Fewtrell M; Przyrembel H; Dumas C; Titz A; Turck D
    EFSA J; 2022 Mar; 20(3):e07141. PubMed ID: 35281653
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tolerance of a standard intact protein formula versus a partially hydrolyzed formula in healthy, term infants.
    Berseth CL; Mitmesser SH; Ziegler EE; Marunycz JD; Vanderhoof J
    Nutr J; 2009 Jun; 8():27. PubMed ID: 19545360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Randomized Controlled Trial Assessing Growth of Infants Fed a 100% Whey Extensively Hydrolyzed Formula Compared With a Casein-Based Extensively Hydrolyzed Formula.
    Fields D; Czerkies L; Sun S; Storm H; Saavedra J; Sorensen R
    Glob Pediatr Health; 2016; 3():2333794X16636613. PubMed ID: 27336009
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Growth of infants fed formula rich in canola oil (low erucic acid rapeseed oil).
    Rzehak P; Koletzko S; Koletzko B; Sausenthaler S; Reinhardt D; Grübl A; Bauer CP; Krämer U; Bollrath C; von Berg A; Berdel D; Wichmann HE; Heinrich J;
    Clin Nutr; 2011 Jun; 30(3):339-45. PubMed ID: 21130544
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Formula versus donor breast milk for feeding preterm or low birth weight infants.
    Quigley M; Embleton ND; McGuire W
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD002971. PubMed ID: 29926476
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Whey predominant, whey modified infant formula with protein/energy ratio of 1.8 g/100 kcal: adequate and safe for term infants from birth to four months.
    Räihä NC; Fazzolari-Nesci A; Cajozzo C; Puccio G; Monestier A; Moro G; Minoli I; Haschke-Becher E; Bachmann C; Van't Hof M; Carrié Fässler AL; Haschke F
    J Pediatr Gastroenterol Nutr; 2002 Sep; 35(3):275-81. PubMed ID: 12352513
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Growth and tolerance of healthy, term infants fed lower protein extensively hydrolyzed or amino acid-based formula: double-blind, randomized, controlled trial.
    Adams CB; Johnston WH; Deulofeut H; Leader J; Rhodes R; Yeiser M; Harris CL; Wampler JL; Hill RJ; Cooper T
    BMC Pediatr; 2021 Jul; 21(1):323. PubMed ID: 34289820
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of Growth of Healthy Term Infants Fed Extensively Hydrolyzed Protein- and Amino Acid-Based Infant Formulas.
    Borschel MW; Baggs GE; Oliver JS
    Nutrients; 2018 Mar; 10(3):. PubMed ID: 29494498
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three-year results of the German Infant Nutritional Intervention Study.
    von Berg A; Koletzko S; Filipiak-Pittroff B; Laubereau B; Grübl A; Wichmann HE; Bauer CP; Reinhardt D; Berdel D;
    J Allergy Clin Immunol; 2007 Mar; 119(3):718-25. PubMed ID: 17240440
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adequacy of Infant Formula With Protein Content of 1.6 g/100 kcal for Infants Between 3 and 12 Months.
    Ziegler EE; Fields DA; Chernausek SD; Steenhout P; Grathwohl D; Jeter JM; Nelson SE; Haschke F
    J Pediatr Gastroenterol Nutr; 2015 Nov; 61(5):596-603. PubMed ID: 26154030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protein hydrolysate versus standard formula for preterm infants.
    Ng DHC; Klassen J; Embleton ND; McGuire W
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012412. PubMed ID: 28968486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.